These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic and environmental factors in the pathogenesis of Parkinson's disease. Mizuno Y; Shimoda-Matsubayashi S; Matsumine H; Morikawa N; Hattori N; Kondo T Adv Neurol; 1999; 80():171-9. PubMed ID: 10410718 [No Abstract] [Full Text] [Related]
4. Idiopathic Parkinson's disease: a genetic and environmental model. Williams AC; Smith ML; Waring RH; Ramsden DB Adv Neurol; 1999; 80():215-8. PubMed ID: 10410724 [No Abstract] [Full Text] [Related]
5. Life style risks of Parkinson's disease: association between decreased water intake and constipation. Ueki A; Otsuka M J Neurol; 2004 Oct; 251 Suppl 7():vII18-23. PubMed ID: 15505750 [TBL] [Abstract][Full Text] [Related]
6. Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease? Collins MA; Neafsey EJ; Matsubara K; Cobuzzi R; Albores R; Fields J; Rollema H Ann N Y Acad Sci; 1992 May; 648():263-5. PubMed ID: 1637053 [No Abstract] [Full Text] [Related]
7. The role of the environment in Parkinson's disease. Gorrell JM; DiMonte D; Graham D Environ Health Perspect; 1996 Jun; 104(6):652-4. PubMed ID: 8793354 [No Abstract] [Full Text] [Related]
8. [Neurotoxin candidates as pathogenic agents of Parkinson's disease]. Naoi M No To Shinkei; 1997 Sep; 49(9):793-803. PubMed ID: 9310995 [No Abstract] [Full Text] [Related]
9. Neurotoxicity and neuroprotection in Parkinson's disease. Lange KW; Youdim MB; Riederer P J Neural Transm Suppl; 1992; 38():27-44. PubMed ID: 1491247 [TBL] [Abstract][Full Text] [Related]
10. Frequency of bowel movements and the future risk of Parkinson's disease. Abbott RD; Petrovitch H; White LR; Masaki KH; Tanner CM; Curb JD; Grandinetti A; Blanchette PL; Popper JS; Ross GW Neurology; 2001 Aug; 57(3):456-62. PubMed ID: 11502913 [TBL] [Abstract][Full Text] [Related]